Skip to main content
Response Biomedical Corp logo

Response Biomedical Corp — Investor Relations & Filings

Ticker · RBM ISIN · CA76123L3039 LEI · 894500A4GGDZZOJ6A354 TSX Manufacturing
Filings indexed 173 across all filing types
Latest filing 2016-12-05 Regulatory Filings
Country CA Canada
Listing TSX RBM

About Response Biomedical Corp

https://responsebio.com/

Response Biomedical Corp. specializes in developing, manufacturing, and marketing rapid, quantitative point-of-care (POC) diagnostic testing solutions. The company's flagship product is the RAMP® system (Rapid Assay Measurement Platform), which includes modular instruments like the RAMP 200 and associated high-quality immunoassays. The RAMP system is designed to deliver central lab-quality results in minutes, supporting faster triage and informed clinical decisions in acute care settings. Key diagnostic areas addressed include cardiovascular health (e.g., Troponin I, NT-proBNP), infectious disease, sepsis, and women's health. The platform emphasizes efficiency, accuracy, and reliability, helping to reduce turnaround times and improve patient outcomes globally.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2016-12-05 English
Other.pdf
Regulatory Filings
2016-12-02 English
Other.pdf
Regulatory Filings
2016-12-01 English
Notice.pdf
Regulatory Filings
2016-11-29 English
News release - English.pdf
Regulatory Filings
2016-11-29 English
Material change report - English.pdf
Regulatory Filings
2016-11-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.